B+
Bull case
20%
Probability
Target price
$79.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
BTSG
BrightSpring Health ServicesCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Strong Q2 growth, improved leverage, a $300 million first-lien paydown, interest savings, and raised FY2026 guidance support continued earnings and cash-generation momentum. [#SEC-8K-2026-07-31]
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-10-30 · BMO.
What can break
Analyst revision, options, short-interest, employee-sentiment, and social data are unavailable in the packet.
Momentum
69
Value
55
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $66.00 · Bull $79.00 · Bear $47.00Analysis 2026-09-03; returns require an exact persisted reference.
Earnings
2026-10-30 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $78.94
Why
Momentum69 · Δ7d +1.3
Value55 · Δ7d +0.5
Sentiment53 · Δ7d -0.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-10-30 · BMO.
- • Value remains the lead driver in the composite, 7D delta +0.5.
Contradictions & invalidation
- • Analyst revision, options, short-interest, employee-sentiment, and social data are unavailable in the packet.
- • Execution, refinancing, and deleveraging risks remain despite leverage improving to 2.15x. [#SEC-8K-2026-07-31]
- • The stock has already experienced a 15.95% 30-day decline, while secondary valuation context cites a 51x P/E versus 25.6x for US healthcare and 39.2x for peers.
Catalyst clock
2026-10-30 · BMO
Q2 results and raised FY2026 guidance
Lead driver: Value · See fundamentals
Momentum
69
8% active weight
Current posture
7d trendSoftening
Δ7d
+1.3
Δ21d
+23.6
Value
55
47% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
+0.6
Sentiment
53
45% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-9.8
Why this grade
Composite grade C. Momentum 68.7 / Value 55.0 / Sentiment 53.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$66.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$47.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$11.65B
Beta
-
Shares Out
197.86M
P/E (TTM)
114.6
P/S (TTM)
0.57
P/FCF (TTM)
25.65
Rev YoY
+23.0%
EPS YoY
+201.8%
Gross Margin
+12.4%
Op Margin
+3.7%
Net Debt
$2.62B
Current Ratio
1.59
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data